Target intelligence / Profile preview

Long intergenic non-protein coding RNA 317 (LINC00317)

Target
LINC00317
Molecular classification
Long non-coding RNA (lncRNA), Other (gene regulator)
01

Overview

Long intergenic non-protein coding RNA 317 (LINC00317) is a long non-coding RNA gene located at cytogenetic region 21q21.1 and annotated as ENSG00000238265 in Ensembl and 378828 in NCBI Gene. LINC00317 does not encode a protein but contributes to gene regulation at the RNA level, primarily through modulating transcription, epigenetic states, or interactions with proteins and other RNAs. Recent evidence implicates LINC00317 as a candidate molecular biomarker for cancer diagnosis and stratification, especially in non-small cell lung cancer, where it has been used in machine learning classification models to distinguish cancerous from normal tissues with high sensitivity and specificity. There is currently no evidence that LINC00317 acts as a classical therapeutic target (e.g., receptor, enzyme), nor are there drugs known to interact with or modulate its function directly. Its utility and role are primarily in molecular diagnostics and potentially as a tool for understanding disease mechanisms in oncology.

Other names
LINC00317PRED89C21orf117NCRNA00317
02

Biological functions

Gene regulation (epigenetic and transcriptional modulation)Potential involvement in carcinogenesis and cell proliferationPossible biomarker for disease diagnosis/prognostics, especially in cancers such as lung and breast cancer
03

Disease associations

Cancer (notably non-small cell lung cancer and potentially breast cancer)Possible roles in other diseases via genome-wide association studies (GWAS) signals, but evidence so far centers on oncology
04

Safety considerations

None specifically documentedGeneral challenges with lncRNA biomarkers include variability in expression, context-dependent function, and lack of established therapeutic modulation; clinical translation as a biomarker may face specificity and sensitivity hurdles
05

Biomarkers

LINC00317 has been identified as a biomarker in molecular diagnostics for cancer, especially for distinguishing tumor from normal tissue and informing prognostics in non-small cell lung cancerSome GWAS signals also indicate possible roles as genetic risk biomarkers

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 317 (LINC00317).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 317 (LINC00317).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call